TBCRC 008: Early Change in <sup>18</sup>F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast CancerRoisín M. Connolly, Vered Stearns, Joyce Mhlanga et al.|Journal of Nuclear Medicine|2014Cited by 65
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008Roisín M. Connolly, Saraswati Sukumar, Mary Jo Fackler et al.|Breast Cancer Research and Treatment|2017Cited by 18
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancerMichelle A. Rudek, Antonio C. Wolff, Roisín M. Connolly et al.|Breast Cancer Research and Treatment|2013Cited by 17